Biomx Inc

Selecta Biosciences, based in Gaithersburg, MD, recently announced a merger with Cartesian Therapeutics, focusing on pioneering mRNA cell therapy for autoimmune diseases. The company is committed to developing potent yet safer cell therapies for patients with autoimmune diseases through their clinical trials and pipeline of therapeutic candidates. With a team of integrated physicians and scientists, Selecta Biosciences is dedicated to creating the safest and most effective mRNA cell therapies for patients. Cartesian Therapeutics reports full year financial results and provides business updates, with topline data from their phase 2b study of Descartes 08 on track for mid-2024. Generated from the website

Mimetas is a leading company in Gaithersburg, MD that specializes in drug discovery and preclinical research. They offer a range of resources and support for scientists, partners, and customers worldwide, including peer-reviewed publications, blogs, case studies, webinars, and events. With their innovative 3D tissue culture technology, Mimetas is revolutionizing drug discovery by providing unmatched disease relevance, precision, throughput, and ethical commitment. Their organ-on-a-chip technology recreates physiologically relevant environments on a large scale, making them a trusted partner for global pharmaceutical and biotech companies. Mimetas is dedicated to advancing preclinical predictivity with their human organ models, supporting ADME and safety with enhanced translatability while minimizing reliance on animal models. They offer a wide range of preclinical research applications, including perfused tubules, 3D cell migration, vascularization, and cell-cell interactions. With 10 years of impactful science, Mimetas is committed to leveraging their 3D tissue expertise to provide tailored answers to unique research questions. Their state-of-the-art modeling technologies enable collaborations in drug discovery, prioritization and optimization, and compound analysis. The quality and value they offer have earned them the trust of leading global pharmaceutical and biotech companies.Generated from the website

Tru Cytonics Institute LLC, established in 2016 and located in Rockville, Maryland, is dedicated to providing specialized services within the healthcare sector. The company is overseen by Chief Operating Officer Lee Emrich and is involved in various government bids, showcasing its commitment to serving public sector needs. With a focus on innovation and quality, Tru Cytonics is strategically positioned to partner with other firms within the medical and technological industries. The institute's presence in the local market emphasizes its role as a key player in the healthcare solutions and services landscape. Generated from the website